Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002422446 | SCV002730311 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2024-02-07 | criteria provided, single submitter | clinical testing | The p.S698F variant (also known as c.2093C>T), located in coding exon 18 of the LZTR1 gene, results from a C to T substitution at nucleotide position 2093. The serine at codon 698 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Medical Genetics Unit, |
RCV003315249 | SCV004012956 | uncertain significance | Diffuse midline glioma, H3 K27-altered | 2022-05-30 | criteria provided, single submitter | research | |
Baylor Genetics | RCV003465430 | SCV004193629 | uncertain significance | Schwannomatosis 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003718275 | SCV004511668 | uncertain significance | not provided | 2022-11-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects LZTR1 function (PMID: 31044557). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LZTR1 protein function. ClinVar contains an entry for this variant (Variation ID: 548121). This variant has not been reported in the literature in individuals affected with LZTR1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 698 of the LZTR1 protein (p.Ser698Phe). |
Rare Disease Group, |
RCV000735828 | SCV000778868 | uncertain significance | Bladder exstrophy | no assertion criteria provided | research |